Corcept Therapeutics
CORT
#2178
Rank
NZ$15.56 B
Marketcap
NZ$144.02
Share price
-5.62%
Change (1 day)
14.51%
Change (1 year)

Earnings for Corcept Therapeutics (CORT)

Earnings in 2026 (TTM): NZ$11.97 Million

According to Corcept Therapeutics 's latest financial reports the company's current earnings are NZ$0.83 Billion. In 2025 the company made an earning of NZ$79.53 Million a decrease over its 2024 earnings that were of NZ$0.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Corcept Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$11.97 M-84.94%
2025 NZ$79.53 M-67.29%
2024 NZ$0.24 B27.66%
2023 NZ$0.19 B-4.75%
2022 NZ$0.19 B-9.51%
2021 NZ$0.22 B-2.91%
2020 NZ$0.22 B14.87%
2019 NZ$0.19 B24.71%
2018 NZ$0.15 B69.32%
2017 NZ$93.83 M419.26%
2016 NZ$18.07 M-395.64%
2015 -NZ$6.12 Million-87.53%
2014 -NZ$49.04 Million-33.44%
2013 -NZ$73.68 Million
2011 -NZ$57.41 Million17.84%
2010 -NZ$48.72 Million35.5%
2009 -NZ$35.96 Million2.84%
2008 -NZ$34.96 Million60.81%
2007 -NZ$21.74 Million-52.14%
2006 -NZ$45.43 Million20.91%
2005 -NZ$37.57 Million31.87%
2004 -NZ$28.49 Million60.54%
2003 -NZ$17.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.52 B 409,080.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.55 B 242,241.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$12.26 B 107,737.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$59.64 B 524,421.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.65 B 119,962.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$21.14 B 185,848.48%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-NZ$86.39 Million-859.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ$0.14 B 1,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$0.26 B 2,228.02%๐Ÿ‡บ๐Ÿ‡ธ USA